Natera, Inc.·4

Apr 3, 9:05 PM ET

RABINOWITZ DANIEL 4

4 · Natera, Inc. · Filed Apr 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Natera (NTRA) Chief Legal Officer Daniel Rabinowitz Sells Shares

What Happened
Daniel Rabinowitz, Natera’s Secretary and Chief Legal Officer, sold a total of 8,400 NTRA shares in multiple open-market transactions on April 1, 2026, generating roughly $1,707,814 in proceeds. The sales were reported as five tranches:

  • 300 shares at a weighted avg price $200.79 — proceeds $60,236 (prices ranged $200.47–$200.99)
  • 1,778 shares at $202.01 — proceeds $359,167 (prices ranged $201.4950–$202.4700)
  • 3,213 shares at $203.07 — proceeds $652,470 (prices ranged $202.51–$203.46)
  • 1,200 shares at $203.83 — proceeds $244,591 (prices ranged $203.52–$204.25)
  • 1,909 shares at $205.00 — proceeds $391,350 (prices ranged $204.54–$205.50)
    All transactions are coded "S" (sale). Sales are typically routine dispositions; they are not inherently a bullish signal.

Key Details

  • Transaction date: April 1, 2026; Form 4 filed April 3, 2026 (timely filing).
  • Total shares sold: 8,400; total proceeds: ≈ $1,707,814.
  • Reported prices are weighted averages; the filing provides per-tranche price ranges (see bullets above).
  • Footnote F1: These sales were executed under a pre-established Rule 10b5‑1 trading plan adopted Dec 5, 2025. Footnotes F2–F6 disclose the specific price ranges for each tranche.
  • Shares owned after the transactions: not specified in the provided filing details.
  • Transaction code: S = Sale.

Context

  • A 10b5‑1 plan allows insiders to sell according to a preset schedule, which can reduce the appearance of trading on inside information; it does not prove intent.
  • For retail investors, purchases by insiders tend to carry more informational weight than routine sales; note this was a planned sale program rather than an ad hoc market sell.

Insider Transaction Report

Form 4
Period: 2026-04-01
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-04-01$200.79/sh300$60,236232,985 total
  • Sale

    Common Stock

    [F1][F3]
    2026-04-01$202.01/sh1,778$359,167231,207 total
  • Sale

    Common Stock

    [F1][F4]
    2026-04-01$203.07/sh3,213$652,470227,994 total
  • Sale

    Common Stock

    [F1][F5]
    2026-04-01$203.83/sh1,200$244,591226,794 total
  • Sale

    Common Stock

    [F1][F6]
    2026-04-01$205.00/sh1,909$391,350224,885 total
Footnotes (6)
  • [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.47 to $200.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.4950 to $202.4700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.51 to $203.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.52 to $204.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.54 to $205.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Tami Chen, Attorney-in-Fact|2026-04-03

Documents

1 file
  • 4
    form4-04032026_090404.xmlPrimary